摘要
目的探讨术前HBV—DNA载量对肝细胞癌(hepatocellularcarcinoma,HCC)术后肝功能衰竭(posthepatectomyliverfailure,PHLF)的影响。方法回顾性分析342例术前肝功能Child—PughA级HCC患者行肝切除术的临床资料,根据术前HBV—DNA不同载量进行分组,比较术前HBV—DNA载量与PHLF发生的关系。结果术后发生PHLF99例(29.O%oPHLF总发生率≥1061U/mL组为42.6%(20/47)、105IU/mL组为29.2%(21H2)、104IU/mL组为34.9%(22/63)、103IU/mL组为19.7%(11/56)、〈103IU/mL组为24.0%(25/104),差异无统计学意义(x2=8.900,P=0.064);PHLF—B级及以上的发生率分别为21-3%(10/47)、16.7%(12/72)、19.0%(12/63)、10.7%(6/56)、13.5%(14/104),差异亦无统计学意义(x2=3.118,P=O.538)。根据术前HBV—DNA不同载量进一步行亚组分析PHLF—B级及以上发生率,各亚组间比较差异均无统计学意义(P〉0.05).结论 术前HBV—DNA载量对PHLF-B级及以上发生无明显影响,对于肝功能Child—PughA级患者,术前经简单抗病毒治疗后应尽快手术。
Objective The purpose of this study was to explore the impact of preoperative HBV-DNA levels on posthepatectomy liver failure (PHLF). Methods This prospective cohort study included 342 consecutive Child-Pugh A hepatocellular carcinoma patients who underwent partial hepatectomy. Possible correlations were explored between preoperative HBV-DNA load and PHLF. Results Of the 342 patients, 99 (29.0%) developed PHLF. Incidence of PHLF by preoperative HBV-DNA load was as follows: 〉 106 IU/mL, 42.6% ( 20/47 ) ; 105 IU/mL, 29.2% ( 21/72 ) ; l04 IU/mL, 34.9% ( 22/63 ) ; l03 IU/mL, 19.7% ( 11/56 ) ; and 〈103 1U/mL, 24.0%(25/104). The association between PHLF and HBV-DNA load was not significant (X2=8.900, P=0.064 ). Similarly,the association between incidence of PHLF-B and HBV-DNA load was not slgnificant(x2=3.118 ,P=0.538 ):〉106 IU/mL, 21.3%( 10/47 ); l05 IU/mL, 16.7% ( 12/72 ) ; 104 IU/mL, 19.0% ( 12/63 ); 103 IU/mL, 10.7% (6/56) ;and 〈lO3 IU/mL, 13.5% ( 14/104 ). Conclusions Preoperative HBV-DNA load level does not appear to be related to the incidence of PHLF at Child-Pugh ]evel B or above. This suggests that simple antiviral treatment can be started as soon as possible after surgery in hepatocellular carcinoma patients with Child-Pugh A liver function.
出处
《中国癌症防治杂志》
CAS
2016年第2期100-103,共4页
CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金
区域性高发肿瘤防治研究教育部重点实验室自主课题(GKE2015-ZZ01)